Skip to main content
logo
Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China flag China · Delayed Price · Currency is CNY
58.47
+0.68 (1.18%)
At close: Aug 27, 2026

SHA:688192 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
968.83801.14359.991.29-10.29
Revenue Growth
89.46%122.60%294.25%---62.95%
Gross Profit
929.33766.91350.5883.63-3.65-2.65
Operating Income
-656.86-819.97-972.43-1,155-792.55-674.37
Net Income
-597.06-764.05-845.96-1,108-736-669.88
Earnings Per Share
-1.29-1.71-2.04-2.72-1.82-1.86
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,7361,936839.99748.21,4162,075
Total Debt
1,3551,2411,157410.3785.2787.76
Net Cash (Debt)
380.92695.51-317.39337.831,3311,987
Net Cash Growth
-64.49%---74.62%-33.02%231.62%
Net Cash Per Share
0.821.56-0.770.833.295.52

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-597.96-588.32-650.53-967.88-603.37-492.28
Capital Expenditures
-104.93-170.47-137.58-32.13-73.78-8.98
Free Cash Flow
-702.9-758.79-788.1-1,000-677.15-501.26
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
95.92%95.73%97.41%91.61%--25.72%
Operating Margin
-67.80%-102.35%-270.19%-1265.43%--6556.55%
Pretax Margin
-61.99%-95.75%-261.09%-1213.31%--6512.85%
Profit Margin
-61.63%-95.37%-235.05%-1213.42%--6512.85%
FCF Margin
-72.55%-94.72%-218.98%-1095.44%--4873.51%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
27.7533.1647.89213.94-1454.37